EVOK logo

Evoke Pharma (EVOK)

Profile

Full Name

Evoke Pharma, Inc.

Ticker Symbol

EVOK

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

September 25, 2013

Indexes

Not included

Website

http://www.evokepharma.com

Employees

3

Key Details

Price

$2.15(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$10.25M(+97.84% YoY)

Annual EPS

-$2.81(+89.95% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.15
EVOK price is $2.15

30-Day Relative Volume

0.30
EVOK 30-day relative volume is 0.30

Price Performance

Price Most recent change

0%
EVOK {parameterFullLabel} has remained unchanged on Apr 17, 2025

Price YTD change

-51.36%
EVOK price is down -51.36% since January 1st

Price 1-year change

-67.37%
EVOK price is down -67.37% year-on-year

Price 3-year change

-96.1%
EVOK price is down -96.1% over the past 3 years

Price Range

Price All-time high

$2014.56
EVOK price is currently -99.89% below its historical high of $2014.56

Price 3-year low

$0.40
EVOK price is currently +437.47% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.21M
EVOK market capitalization is $3.21 million

Market cap 3-year change

-74.54%
EVOK market capitalization is down -74.54% over the past 3 years

Market cap All-time high

$148.24M
EVOK market capitalization is currently -97.83% below its historical high of $148.24 million

Market cap sector rank

9.29%
EVOK market capitalization is higher than 9.29% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+108.36%
EVOK shares outstanding is up +108.36% year-on-year

Shares Outstanding 3-Year Change

+553.06%
EVOK shares outstanding is up +553.06% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.78
EVOK beta is 0.78

200-day SMA

$4.67
EVOK price is currently -54.00% below its 200-day simple moving average

50-day SMA

$3.60
EVOK price is currently -40.24% below its 50-day simple moving average

RSI

28.95
EVOK 14-day relative strength index is 28.95

Volume

0.30
EVOK 30-day relative volume is 0.30

ATR

$0.23
EVOK average true range is $0.23

10-day Historical Volatility

85.59%
EVOK 10-day historical volatility is 85.59%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$10.25M
EVOK annual revenue is $10.25 million

Revenue Analysts estimate

$15.96M
EVOK annual revenue is currently -35.78% lower than the consensus analysts' forecast

Revenue 1-year change

+97.84%
EVOK annual revenue is up +97.84% year-on-year

Revenue Sector rank

28.7%
EVOK annual revenue is higher than 28.7% of companies in Healthcare sector

EPS

EPS

-$2.81
EVOK annual earnings per share is -$2.81

EPS Analysts estimate

-$0.81
EVOK annual earnings per share is currently +246.91% higher than the consensus analysts' forecast

EPS 1-year change

+89.95%
EVOK annual earnings per share is up +89.95% year-on-year

EPS Sector rank

31.4%
EVOK annual earnings per share is higher than 31.4% of companies in Healthcare sector

Profit

Gross profit

$9.89M
EVOK annual gross profit is $9.89 million

Gross margin

96.52%
EVOK annual gross profit margin is 96.52%

Operating profit

-$5.20M
EVOK annual operating income is -$5.20 million

Operating margin

-50.78%
EVOK annual operating profit margin is -50.78%

Net income

-$5.35M
EVOK annual net profit is -$5.35 million

Net margin

-52.22%
EVOK annual net profit margin is -52.22%

Expenses

Total expenses

$15.45M
EVOK annual total expenses is $15.45 million

Operating expenses

$15.10M
EVOK annual total operating expenses is $15.10 million

Cost of goods sold

$356.50K
EVOK annual cost of goods sold is $356.50 thousand

Selling, general & administrative expenses

$15.08M
EVOK annual SGA is $15.08 million

Depreciation and amortization

-
EVOK annual depreciation & amortization value is unknown

Interest expense

$501.40K
EVOK annual interest expense is $501.40 thousand

Income tax

-
EVOK annual income tax value is unknown

EBIT & EBITDA

EBIT

-$4.85M
EVOK annual earnings before interest & taxes is -$4.85 million

EBITDA

-$4.85M
EVOK annual EBITDA is -$4.85 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$17.52M
EVOK annual total assets is $17.52 million

Non current assets

$281.10K
EVOK annual long term assets is $281.10 thousand

Current assets

$17.24M
EVOK annual total current assets is $17.24 million

Cash and cash equivalents

$13.60M
EVOK annual cash & cash equivalents is $13.60 million

Accounts receivable

$2.42M
EVOK annual accounts receivable is $2.42 million

Inventory

$445.10K
EVOK annual inventory is $445.10 thousand

Liabilities

Total liabilities

$10.48M
EVOK annual total liabilities is $10.48 million

Long term liabilities

$101.00K
EVOK annual total long term liabilities is $101.00 thousand

Current liabilities

$10.38M
EVOK annual total current liabilities is $10.38 million

Accounts payable

$2.34M
EVOK annual accounts payable is $2.34 million

Debt

Total debt

$5.16M
EVOK annual total debt is $5.16 million

Total debt 1-year change

+3.21%
EVOK annual total debt is up +3.21% year-on-year

Long term debt

$101.00K
EVOK annual long term debt is $101.00 thousand

Short term debt

$5.06M
EVOK annual short term debt is $5.06 million

Equity & Capital

Shareholders equity

$7.04M
EVOK annual stockholders equity is $7.04 million

Book value

$7.04M
EVOK annual book value is $7.04 million

Retained earnings

-$128.79M
EVOK annual retained earnings is -$128.79 million

Working capital

$6.86M
EVOK annual working capital is $6.86 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$5.46M
EVOK annual cash flow from operations is -$5.46 million

Cash from operations 1-year change

-9.5%
EVOK annual cash flow from operations is down -9.5% year-on-year

Cash from investing

-
EVOK annual cash flow from investing activities value is unknown

Cash from investing 1-year change

-
EVOK annual cash flow from investing activities 1-year change is unknown

Cash from financing

$14.32M
EVOK annual cash flow from financing activities is $14.32 million

Cash from financing 1-year change

+12099.92%
EVOK annual cash flow from financing activities is up +12099.92% year-on-year

CAPEX

CAPEX

-
EVOK annual capital expenditures value is unknown

CAPEX 1-year change

-
EVOK annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$5.46M
EVOK annual free cash flow is -$5.46 million

Free cash flow 1-year change

-9.5%
EVOK annual free cash flow is down -9.5% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

96.52%
EVOK annual gross profit margin is 96.52%

Operating margin

-50.78%
EVOK annual operating profit margin is -50.78%

Net margin

-52.22%
EVOK annual net profit margin is -52.22%

ROA & ROE

ROA

-43.54%
EVOK annual return on assets is -43.54%

ROE

-240.09%
EVOK annual return on equity is -240.09%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
EVOK price to earnings ratio value is unknown

PE ratio Sector rank

-
EVOK price to earnings ratio is unknown

PB Ratio

PB ratio

0.46
EVOK price to book ratio is 0.46

PB ratio Sector rank

28.58%
EVOK price to book ratio is higher than 28.58% of companies in Healthcare sector

PS Ratio

PS ratio

0.31
EVOK price to sales ratio is 0.31

PS ratio Sector rank

10.51%
EVOK price to sales ratio is higher than 10.51% of companies in Healthcare sector

Enterprise value

Enterprise value

-$5.23M
EVOK enterprise value is -$5.23 million

Enterprise value Sector rank

6.36%
EVOK enterprise value is higher than 6.36% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

1.08
EVOK EV/EBITDA is 1.08

EV/EBITDA Sector rank

74.87%
EVOK EV/EBITDA is higher than 74.87% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.66
EVOK annual current ratio is 1.66

Quick ratio

1.62
EVOK annual quick ratio is 1.62

Leverage

Debt to equity

0.71
EVOK annual debt to equity ratio is 0.71

Interest coverage ratio

-9.67
EVOK annual interest coverage ratio is -9.67

Risk & Stability

Piotroski F-Score

2
EVOK piotroski f-score is 2

Altman Z-Score

-9.97
EVOK altman z-score is -9.97

Analyst ratings

Recent major analysts updates

Jun 22, 20 HC Wainwright & Co.
Buy
Mar 5, 19 H.C. Wainwright
Neutral
Oct 6, 17 Seaport Global
Buy
Jan 30, 17 Laidlaw & Co.
Buy
Jan 5, 17 Rodman & Renshaw
Buy
Jul 19, 16 Noble Financial
Hold
Jul 18, 16 Rodman & Renshaw
Neutral
Jul 18, 16 Brean Capital
Hold
Mar 16, 16 Northland Securities
Outperform
Mar 14, 16 Ascendiant Capital
Buy

Institutional Ownership

Similar stocks

GLTO logo
Galecto (GLTO)
QNRX logo
Quoin Pharmaceuticals (QNRX)
PALI logo
Palisade Bio (PALI)
INM logo
InMed Pharmaceuticals (INM)
ARTL logo
Artelo Biosciences (ARTL)
TLIS logo
Talis Biomedical (TLIS)
XRTX logo
XORTX Therapeutics (XRTX)
SPRC logo
SciSparc (SPRC)
MTNB logo
Matinas BioPharma Holdings (MTNB)
  • What is the ticker symbol for Evoke Pharma?
  • Does Evoke Pharma pay dividends?
  • What sector is Evoke Pharma in?
  • What industry is Evoke Pharma in?
  • What country is Evoke Pharma based in?
  • When did Evoke Pharma go public?
  • Is Evoke Pharma in the S&P 500?
  • Is Evoke Pharma in the NASDAQ 100?
  • Is Evoke Pharma in the Dow Jones?
  • When was Evoke Pharma's last earnings report?
  • When does Evoke Pharma report earnings?
  • Should I buy Evoke Pharma stock now?

What is the ticker symbol for Evoke Pharma?

The ticker symbol for Evoke Pharma is NASDAQ:EVOK

Does Evoke Pharma pay dividends?

No, Evoke Pharma does not pay dividends

What sector is Evoke Pharma in?

Evoke Pharma is in the Healthcare sector

What industry is Evoke Pharma in?

Evoke Pharma is in the Drug Manufacturers - Specialty & Generic industry

What country is Evoke Pharma based in?

Evoke Pharma is headquartered in United States

When did Evoke Pharma go public?

Evoke Pharma's initial public offering (IPO) was on September 25, 2013

Is Evoke Pharma in the S&P 500?

No, Evoke Pharma is not included in the S&P 500 index

Is Evoke Pharma in the NASDAQ 100?

No, Evoke Pharma is not included in the NASDAQ 100 index

Is Evoke Pharma in the Dow Jones?

No, Evoke Pharma is not included in the Dow Jones index

When was Evoke Pharma's last earnings report?

Evoke Pharma's most recent earnings report was on Mar 13, 2025

When does Evoke Pharma report earnings?

The next expected earnings date for Evoke Pharma is May 14, 2025

Should I buy Evoke Pharma stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page